Purchase Order HHSN261201600713P

This is a $114,966.00 firm-fixed-price purchase order awarded by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) to Gene Square Bio-Technology LTD, a for-profit limited liability company based in China. The contract is for genetic studies of myeloid and lymphoid malignancy in China in support of NCI's Division of Cancer Epidemiology and Genetics. The work will involve scanning 2,129 DNA samples from the NCI's AsiaLymph study...

This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Gene By Gene, LIMITED, a for-profit organization, for $16,268.00. The contract is for research SNP (single nucleotide polymorphism) arrays to support NIAID's Centralized Sequencing Initiative, which aims to understand the genetic etiology of diseases and provide genomic evaluations for NIH patients. No...

<p>This is a $299,999.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian agency, to Innogenomics Technologies, L.L.C., a minority-owned small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for research and development in the area of biomedical (basic research). It was awarded on September 22, 2015 with a final completion date of March 21, 2017. The contract has a total small business set-aside designation.</p>

<p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed-price purchase order to Genus Biosystems Inc., a for-profit organization, for $23,520.00 to provide lab testing services. The contract has a completion date of November 1, 2024 and was awarded on May 1, 2024. The place of performance is Northbrook, IL 60062, USA. This contract award is not associated with any set-aside designation.</p>

This federal contract was awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Novogene Corp Inc., a minority-owned small business, to provide laboratory services for fresh-frozen tissue samples from a study of lung cancer in Xuanwei, China. The contract, valued at $117,038.40, is a firm fixed price purchase order for the requested services. Novogene has received over 100 prime contract awards from various federal agencies since 2015...

This firm fixed price purchase order, awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute, is for $37,785.60 in mRNA and microRNA microarray profiling services to support the prediction of radiation therapy outcomes. The prime contractor is Genus Biosystems Inc., located in Northbrook, Illinois, and no set-aside designation was applied to this procurement. The contract completion date is August 19, 2024, suggesting the National Cancer...

The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, has awarded a firm fixed-price purchase order valued at $24,940 to Global Life Sciences Solutions USA LLC. The contract calls for the delivery of an imaging system and associated easy-to-use software for band analysis and quantification of protein and DNA gels. The products and services will support research activities across the Laboratory of Biochemistry and...

This federal contract award, HHSN261201000135C, was issued by the National Cancer Institute, a civilian agency, to the small business prime contractor 20 / 20 Genesystems, Inc. (doing business as 20 / 20 Genomics). The award has a ceiling value of $182,576.00 and is a definitive, firm-fixed-price contract with a completion date of November 29, 2011. The contract is set aside for small businesses. The work to be performed under this contract is described in the solicitation as &quot;TAS::75...

The National Cancer Institute, a component of the National Institutes of Health, awarded Government Scientific Source Inc. a contract call valued at $9,497.55 for molecular biology analysis and sequencing services. Awarded on September 21, 2015, with an ultimate completion date of October 15, 2015, this fixed-price contract with economic price adjustment calls for six samples (equivalent to 7,800 euros) to undergo MBD sequencing and bioinformatics analysis. The work is to be performed in...

The National Cancer Institute (NCI) awarded a $142,009.29 firm fixed-price purchase order contract to Fundacio Centre De Regulacio Genomica, a non-profit biomedical research institute, to perform targeted gene sequencing on samples collected by NCI's Division of Cancer Epidemiology and Genetics. This contract, which does not have a set-aside designation, is expected to be completed by June 2023. The contract was awarded in September 2021 under simplified acquisition procedures for commercial...